To describe the current and lifetime patterns of substance use, particularly cannabis, and its association with clinical presentation of individuals presenting with first episode psychosis, living with and without HIV, in KwaZulu‐Natal Province, South Africa.
There is currently no published evidence demonstrating the effectiveness and safety of subanaesthetic doses of ketamine, when administered intravenously as an adjunct treatment for depressive symptoms, in a real world setting in South Africa. This retrospective chart review reports the clinical response (change in Patient Health Questionnaire - 7 score) to an initial infusion series of ketamine...